CRXT

Clarus Therapeutics (CRXT)

Clarus Therapeutics Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRXT

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/03/07	20 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21 : 36	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21 : 23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21 : 20	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21 : 17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21 : 07	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/02/23	06 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/01/25	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/12/23	06 : 24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/11/23	20 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/10/19	05 : 05	GlobeNewswire Inc.	Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/09/14	22 : 52	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/09/06	11 : 19	GlobeNewswire Inc.	Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/27	05 : 37	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/27	05 : 33	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/27	05 : 30	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/27	05 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/23	01 : 05	TipRanks	Clarus Therapeutics Holdings (CRXT) was downgraded to a Hold Rating at Needham	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	19 : 38	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	19 : 34	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	19 : 32	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	19 : 13	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	05 : 50	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	05 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	05 : 05	GlobeNewswire Inc.	Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/10	19 : 06	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/10	19 : 05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/10	06 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/07/28	22 : 05	GlobeNewswire Inc.	Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/07/07	05 : 00	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc